Synapse - Works

Results (3351)

Clinical and genomic characterization of ERBB2-altered gallbladder cancer

Meeting Abstract

Mondaca, S.; Schultz, N.; Roa, J. C.; Walch, H. S.; Sepulveda, S.; Harding, J. J.; Yaqubie, A.; Garcia, P.; Aguayo, G.; Nervi, B.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Multimodal integration of radiology, pathology, and genomics for prediction of response to PD-1 blockade in patients with non-small cell lung cancer

Meeting Abstract

Luo, J.; Vanguri, R. S.; Aukerman, A. T.; Egger, J. V.; Fong, C. J.; Horvat, N.; Pagano, A.; Araujo-Filho, J.; Geneslaw, L.; Rizvi, H.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Open-label, randomized, multicenter, phase 3 study evaluating trastuzumab deruxtecan (T-DXd) as first-line treatment in patients with unresectable, locally advanced, or metastatic non-small cell lung cancer (NSCLC) harboring HER2 exon 19 or 20 mutations (DESTINY-Lung04)

Meeting Abstract

Li, B. T.; Ahn, M. J.; Goto, K.; Mazieres, J.; Padda, S. K.; William, W. N.; Wu, Y. L.; Dearden, S.; Ragone, A.; Viglianti, N.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Clinicopathologic characterization of ERK2 E322K mutation in solid tumors: Implications for treatment and drug development

Meeting Abstract

Liu, D.; Murciano-Goroff, Y. R.; Jee, J.; Arcila, M. E.; Buonocore, D. J.; Gao, J.; Chakravarty, D.; Schram, A. M.; Callahan, M. K.; Friedman, C. F.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Minimal residual disease (MRD) detection by ctDNA in relation to radiographic disease progression in patients with stage I-III non-small cell lung cancer (NSCLC) treated with definitive radiation therapy

Meeting Abstract

Lebow, E. S.; Murciano-Goroff, Y. R.; Jee, J.; Kalashnikova, E.; Feeney, J.; Sethi, H.; Aleshin, A.; Kris, M. G.; Chaft, J. E.; Rudin, C. M.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Clinical response to tepotinib according to circulating tumor (ct) DNA biomarkers in patients with advanced NSCLC with high-level MET amplification (METamp) detected by liquid biopsy (LBx)

Meeting Abstract

Le, X.; Paz-Ares, L.; Van Meerbeeck, J.; Ramirez, S. V.; Galvez, C. C.; Baz, D. V.; Kim, Y. C.; Kang, J. H.; Stroh, C.; Juraeva, D.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Clinical characteristics and outcome of a large cohort of patients with primary central nervous system (CNS) tumors and tropomyosin receptor kinase (TRK) fusion

Meeting Abstract

Lamoureux, A. A.; Fisher, M. J.; Lemelle, L.; Pfaff, E.; Pfister, S. M.; Sturm, D.; Jones, D. T. W.; Orbach, D.; Raskin, S.; Drilon, A. E.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Updated health-related quality of life of patients with TRK-fusion cancer treated with larotrectinib in clinical trials

Meeting Abstract

Kummar, S.; Shen, L.; van Tilburg, C. M.; Tan, D. S. W.; Doz, F.; McDermott, R. S.; Zwaan, C. M.; Keating, K. N.; Chirila, C.; Norenberg, R.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Tepotinib in Asian patients with advanced NSCLC with MET exon 14 (METex14) skipping

Meeting Abstract

Kato, T.; Yang, J. C. H.; Ahn, M. J.; Sakai, H.; Morise, M.; Chen, Y. M.; Han, J. Y.; Yang, J. J.; Zhao, J.; Huang, J.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Chylothorax and chylous ascites during RET tyrosine kinase inhibitor therapy

Meeting Abstract

Kalchiem-Dekel, O.; Falcon, C. J.; Bestvina, C. M.; Liu, D.; Kaplanis, L. A.; Wilhelm, C.; Eichholz, J.; Harada, G.; Wirth, L. J.; Lee, R. P.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save